Full-Time

Vascular Procedural Specialist II

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Healthcare

Mid, Senior

Boston, MA, USA + 2 more

More locations: Tempe, AZ, USA | Concord, NH, USA

Minimum of 4 days of in-office presence per week required.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Associates or Bachelors degree.
  • Minimum of 3 - 5 years’ experience in the Operating Room, Interventional Radiology Lab, or Cardiac Cath Lab.
  • Current credentialing and/or certification in respective clinical discipline.
  • Strong time management skills with an ability to maintain numerous priorities and meet established deadlines.
  • Self-motivated, takes on additional responsibilities, and manages priorities with minimal supervision.
  • Frequent travel required.
Responsibilities
  • Educate and train physicians, hospital personnel and hospital staff on technical matters relating to BD Peripheral Intervention products through case support, conducting and/or coordinating one-on-one in-servicing, and/or available internal/external physician education training programs.
  • Establishes and maintains relationships with customers, hospitals and physicians. Obtains new users and applications for company products and services.
  • Observes and reports market trends which affect BD Peripheral Intervention sales, service and product development.
  • Represents BD Peripheral Intervention in accordance with policies and procedures.
  • Processes customer complaints and returns in accordance with established procedures and policy.
  • Maintains company automobile and company property.
  • Complete and processes BD Peripheral Intervention reports including but not limited to: Clinical Specialists reports, expense reports, monthly product tracking reports and complaint reports in accordance with established procedures and policies.
  • Fulfills the duty of a Territory Manager in vacant territories and supports endovascular procedures as directed by the District Manager.
Desired Qualifications
  • Product knowledge of all BD Peripheral Intervention Vascular products
  • Surgical and endovascular procedure knowledge, adequate to support clinical cases
  • Vascular anatomy
  • Medical and surgical terminology
  • Advanced knowledge of vascular access management, vascular surgery, and endovascular medicine preferred.

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...